Pitch deck

Healx's pitch deck

The deck, and the 3 rounds we watched Healx raise afterwards, with the investors each report named.

Healx is a clinical-stage biotechnology company based in Cambridge, United Kingdom, founded in 2014. The company focuses on drug discovery for rare diseases, utilizing advanced AI technology to address the significant unmet medical needs of patients affected by these conditions. With over 10,000 known rare diseases impacting around 400 million people globally, Healx aims to accelerate the development of new treatments, targeting to advance 100 therapies towards clinical trials by 2025. The company's proprietary AI drug discovery platform, Healnet, collates extensive biomedical data to identify novel connections between existing drugs and rare diseases. This innovative approach allows Healx to conduct drug discovery processes significantly faster and more cost-effectively than traditional methods. Healx has an active pipeline of drug candidates, including therapies for conditions such as Neurofibromatosis Type 1 and Fragile X Syndrome, and collaborates with major pharmaceutical companies to enhance drug development efforts.

Read the deckFree account. The deck belongs to Healx, so reading it needs one; everything on this page is public.